%A Mohammadreza Bordbar, Mehdi Pasalar, Rezvan Aresehiri, Sezaneh Haghpanah, Soheila Zareifar, Fatemeh Amirmoezi %T A cross-sectional study of complementary and alternative medicine use in patients with coagulation disorders in Southern Iran %0 Journal Article %D 2017 %J Journal of Integrative Medicine %R 10.1016/S2095-4964(17)60343-1 %P 359-364 %V 15 %N 5 %U {http://www.jcimjournal.com/CN/abstract/article_2172.shtml} %8 2017-09-15 %X

Objective

Complementary and alternative medicine (CAM) use has an increasing trend around the world. Despite the wild application of CAM in patients with coagulation disorders, its efficacy is still questioned by many studies. The aim of this study was to determine the frequency and types of CAM usage, and the factors affecting CAM use among patients with bleeding disorders.

Methods

This cross-sectional study investigated the usage of CAM with a standard validated questionnaire in coagulopathic patients who were referred to Dastgheib Hospital, an educational therapeutic center affiliated to the Shiraz University of Medical Sciences in Shiraz, Southern Iran.

Results

Between December 2015 and May 2016, 75 patients were included in this survey. Severe hemophilia A and rare bleeding disorders were the most frequent among our participants. Overall, nearly half of the studied population (49.3%) used at least one CAM product or practices. The most common products were multivitamin (29.3%), followed by folic acid (21.3%) and chamomile (12%). 32% of the patients resorted to faith healing. The main reasons of using CAM were reported to be increased general health, correction of anemia and thrombocytopenia and control of bleeding tendency.

Conclusion

CAM is being used frequently in patients with coagulation disorders like many other chronic illnesses all around the world. Due to emerging concern regarding the safety and possible interaction with the conventional medicine, it is necessary to develop basic data about the hematologic effects of these methods in order to use them more safely.